From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology
A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
FA Iannotti, V Di Marzo, S Petrosino - Progress in lipid research, 2016 - Elsevier
The endocannabinoid system (ECS) is composed of two G protein-coupled receptors
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …
Endocannabinoid system in neurodegenerative disorders
BS Basavarajappa, M Shivakumar… - Journal of …, 2017 - Wiley Online Library
Most neurodegenerative disorders (NDD s) are characterized by cognitive impairment and
other neurological defects. The definite cause of and pathways underlying the progression …
other neurological defects. The definite cause of and pathways underlying the progression …
Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target
As a consequence of an increasingly aging population, the number of people affected by
neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and …
neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and …
The cannabinoid system and microglia in health and disease
SS Duffy, JP Hayes, NT Fiore, G Moalem-Taylor - Neuropharmacology, 2021 - Elsevier
Recent years have yielded significant advances in our understanding of microglia, the
immune cells of the central nervous system (CNS). Microglia are key players in CNS …
immune cells of the central nervous system (CNS). Microglia are key players in CNS …
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
Y Gómez-Gálvez, C Palomo-Garo… - Progress in Neuro …, 2016 - Elsevier
Inflammation is an important pathogenic factor in Parkinson's disease (PD), so that it can
contribute to kill dopaminergic neurons of the substantia nigra and to enhance the …
contribute to kill dopaminergic neurons of the substantia nigra and to enhance the …
Neurotransmitter receptors on microglia
As the resident immune cells in the central nervous system, microglia have long been
hypothesised to promote neuroinflammation and exacerbate neurotoxicity. However, this …
hypothesised to promote neuroinflammation and exacerbate neurotoxicity. However, this …
[HTML][HTML] Cannabinoids in neurodegenerative disorders and stroke/brain trauma: from preclinical models to clinical applications
Cannabinoids form a singular family of plant-derived compounds (phytocannabinoids),
endogenous signaling lipids (endocannabinoids), and synthetic derivatives with multiple …
endogenous signaling lipids (endocannabinoids), and synthetic derivatives with multiple …
Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's chorea, Alzheimer's disease, and others
J Fernández-Ruiz, J Romero, JA Ramos - Endocannabinoids, 2015 - Springer
This review focuses on the role of the endocannabinoid signaling system in controlling
neuronal survival, an extremely important issue to be considered when developing new …
neuronal survival, an extremely important issue to be considered when developing new …
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
ES Onaivi, H Ishiguro, S Gu… - Journal of …, 2012 - journals.sagepub.com
There are two well characterized cannabinoid receptors (CBRs), CB1-Rs and CB2-Rs, with
other candidates, such as GPR55, PPARs and vanilloid TRPV1 (VR1) receptors, which are …
other candidates, such as GPR55, PPARs and vanilloid TRPV1 (VR1) receptors, which are …